Monoclonal antibody EP-5C7

Drug Profile

Monoclonal antibody EP-5C7

Alternative Names: 5C7; Anti-E/P-selectin monoclonal antibody - Protein Design Labs; EP-5C7; HuEP5C7; HuEP5C7 MAb; Monoclonal antibody 5C7.29; SMART anti-E/P-selectin antibody

Latest Information Update: 14 May 2001

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator PDL BioPharma
  • Class Anti-inflammatories; Monoclonal antibodies
  • Mechanism of Action Selectin inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Asthma; Autoimmune disorders; Psoriasis; Shock; Stroke

Most Recent Events

  • 14 May 2001 Discontinued-I for Asthma in USA (Unknown route)
  • 14 May 2001 Discontinued-I for Autoimmune disorders in USA (Unknown route)
  • 14 May 2001 Discontinued-I for Psoriasis in USA (Unknown route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top